Literature DB >> 15974988

Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis.

Andreas G Tzakos1, Anastassios Troganis, Vassiliki Theodorou, Theodore Tselios, Christos Svarnas, John Matsoukas, Vasso Apostolopoulos, Ioannis P Gerothanassis.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterized by demyelination and loss of neurological function, local macrophage infiltrate and neuroantigen-specific CD4(+)T cells. MS arises from complex interactions between genetic, immunological, infective and biochemical mechanisms. Although the circumstances of MS etiology remain hypothetical, one persistent theme involves immune system recognition of myelin-specific antigens derived from myelin basic protein, the most abundant extrinsic myelin membrane protein, and/or another equally suitable myelin protein or lipid. Knowledge of the biochemical and physico-chemical properties of myelin proteins and lipids, particularly their composition, organization, structure and accessibility with respect to the compacted myelin multilayers, becomes central to understanding how and why myelin-specific antigens become selected during the development of MS. This review focuses on the current understanding of the molecular basis of MS with emphasis: (i) on the physical-chemical properties, organization, morphology, and accessibility of the proteins and lipids within the myelin multilayers; (ii) on the structure-function relationships and characterization of the myelin proteins relevant to the manifestation and evolution of MS; (iii) on conformational relationships between myelin epitopes which might become selected during the development of MS; (iv) on the structure of MHC/HLA in complex with MBP peptides as well as with TCR, which is crucial to the understanding of the pathogenesis of MS with the ultimate goal of designed antigen-specific treatments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15974988     DOI: 10.2174/0929867054039026

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  Cysteine thioesters as myelin proteolipid protein analogues to examine the role of butyrylcholinesterase in myelin decompaction.

Authors:  Ian R Pottie; Emma A Higgins; Rachelle A Blackman; Ian R Macdonald; Earl Martin; Sultan Darvesh
Journal:  ACS Chem Neurosci       Date:  2010-12-30       Impact factor: 4.418

Review 2.  Peripheral nerve injury modulates neurotrophin signaling in the peripheral and central nervous system.

Authors:  Mette Richner; Maj Ulrichsen; Siri Lander Elmegaard; Ruthe Dieu; Lone Tjener Pallesen; Christian Bjerggaard Vaegter
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

3.  The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.

Authors:  Maria Podbielska; Steven B Levery; Edward L Hogan
Journal:  Clin Lipidol       Date:  2011-04

Review 4.  A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease.

Authors:  George Harauz; Abdiwahab A Musse
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

Review 5.  Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms.

Authors:  George Harauz; Joan M Boggs
Journal:  J Neurochem       Date:  2013-03-06       Impact factor: 5.372

6.  Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis.

Authors:  Alessandro Massella; Giulia D'Intino; Mercedes Fernández; Sandra Sivilia; Luca Lorenzini; Silvia Giatti; Roberto C Melcangi; Laura Calzà; Luciana Giardino
Journal:  BMC Neurosci       Date:  2012-01-24       Impact factor: 3.288

7.  Association between brain metastasis from lung cancer and the serum level of myelin basic protein.

Authors:  Wei Liu; Jing Zhao; Yujuan Wei
Journal:  Exp Ther Med       Date:  2015-01-20       Impact factor: 2.447

8.  IKAP deficiency in an FD mouse model and in oligodendrocyte precursor cells results in downregulation of genes involved in oligodendrocyte differentiation and myelin formation.

Authors:  David Cheishvili; Paula Dietrich; Channa Maayan; Aviel Even; Miguel Weil; Ioannis Dragatsis; Aharon Razin
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

9.  Combined application of dexamethasone and hyperbaric oxygen therapy yields better efficacy for patients with delayed encephalopathy after acute carbon monoxide poisoning.

Authors:  Wenping Xiang; Hui Xue; Baojun Wang; Yuechun Li; Jun Zhang; Changchun Jiang; Furu Liang; Jiangxia Pang; Lehua Yu
Journal:  Drug Des Devel Ther       Date:  2017-02-23       Impact factor: 4.162

10.  The Long Road of Immunotherapeutics against Multiple Sclerosis.

Authors:  Vasso Apostolopoulos; Abdolmohamad Rostami; John Matsoukas
Journal:  Brain Sci       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.